From: Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma
Deletions | |||||
---|---|---|---|---|---|
Chromosome | Potential tumour specifically inactivated genes | Â | |||
Tum Exp. Lost/Tum. Exp. Down-regulated/Tum. Exp. Normal or Up-regulated (Percentage of lost/down-regulated) | Â | ||||
Chromosome 1 | CHD5 | TNFRSF1B | KIF17 | UQCRH | GPX7 |
0/1/14 (6.7%) | 0/0/15 (0.0%) | 0/0/15 (0.0%) | 0/0/15 (0.0%) | 0/0/15 (0.0%) | |
TTC22 | PDE4DIP | RGS7 | TRIM58 | Â | |
1/1/13 (13.3%) | 0/0/15 (0.0%) | 3/4/8 (46.7%) | 0/2/13 (13.1%) | Â | |
Chromosome 6 | GCM2 | HIST1H3G | HIST1H4H | Â | Â |
8/0/2 (80.0%) | 0/0/15 (0.0%) | 0/0/15 (0.0%) | Â | Â | |
Chromosome 8p | GATA4 | NEFM | Â | Â | Â |
1/0/8 (11.1%) | 1/2/12 (20.0%) | Â | Â | Â | |
Chromosome 14q | EFS | PTGDR | C14orf39 | FLRT2 | Â |
0/1/14 (6.7%) | 0/1/14 (6.7%) | 1/0/8 (11.1%) | 0/1/14 (6.7%) | Â | |
Amplifications | |||||
Chromosome | Potential tumour specifically inactivated genes | Â | |||
 | (Percentage of tumours in which gene expression is lost or down-regulated in brackets) |  | |||
Chromosome 1 | TWIST1 | HOXA11 | AEBP1 | KLF14 | Â |
 | 1/0/13 (7.1%)1 | 0/2/13 (13.3%) | 3/0/12 (20.0%) | 0/2/13 (13.3%) |  |
Chromosome 8p | SOX17 | CA3 | ANGPT1 | TMEM74 | Â |
 | 0/2/13 (13.3%) | 0/3/12 (20.0%) | 0/0/15 (0.0%) | 4/3/8 (46.7%) |  |